WCN26-4434 The effect of therapeutic agents for renal anemia on red blood cell distribution width in pre-dialysis chronic kidney disease patients

Read full text Summarise with VIRAT
Authors: Keiichi Osano, Shun Yoshida, K. Yamamura, Kie Ohkoshi, Miho Shikata, Makiko Konishi, Toshihisa Ishii, Kazuya Takahashi, Ayumu Nakashima
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Red blood cell distribution width (RDW) is an indicator of variation in red blood cell size. An elevated RDW has been reported to be associated with increased mortality. This study investigated the effects of erythropoiesis-stimulating agents (ESAs) and hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHDs) on RDW in predialysis patients with chronic kidney disease (CKD) and renal anemia.

Fields of Study & Subjects

Erythropoietin and Anemia Treatment Dialysis and Renal Disease Management Iron Metabolism and Disorders

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104781–104781
Publication date
25 March 2026
Language
EN